{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/22/3315163/0/en/NRx-Pharmaceuticals-Announces-FDA-Grant-of-Expanded-Access-Protocol-for-Use-of-D-Cycloserine-based-NRX-101-for-Augmentation-of-Transcranial-Magnetic-Stimulation-in-the-Treatment-of.html", "message": "News view counter 808930 successfully enlarged"}